Stock NBIX NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
139.4 USD -0.79% Intraday chart for Neurocrine Biosciences, Inc. -2.03% +5.80%
May. 21 Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing MT
May. 16 Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
 14.03B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Charts Neurocrine Biosciences, Inc.
  5. Sector Chart